StockTipsArenaBeta

BUY Dr. Lal Path Labs Ltd. — Chandan Taparia, Motilal Oswal

BUYDr. Lal Path Labs Ltd.
Dr. Lal Path Labs share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))16 Sept 2026via NDTV Profit

Entry₹2,000.2Inferred
Target₹2,080
Total upside +3.99% (call closed)
Stop loss₹1,920-4.01% risk
Exit₹1,92016 Sept 2026, 9:40 am
Stop-loss hit-4.01%
Follow Chandan Taparia for new calls(35% target hit, 295 closed calls)Get alertsWatch LALPATHLAB for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 16 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·16 Sept · today

Indian Diagnostic Giants Post Strong Q1 FY27 Growth Amid Stable Pricing

NewsGoogle News·13 Sept · 2d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Lal Path Labs

All analyst calls on Dr. Lal Path Labs

More from Chandan Taparia, Motilal Oswal

Every call and its outcome